Advertisement

Topics

NEKTAR Company Profile

14:17 EDT 21st September 2018 | BioPortfolio

We are a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapies, and leverage our knowledge and extensive development expertise to evaluate how they can more effectively impact patients’ lives.Just over 15 years ago, our company was founded on breakthrough ideas that changed the way people thought about disease treatment and introduced new and exciting ways to increase the therapeutic value of medicines. Today, we are developing our own high-value, proprietary products as well as highly differentiated products in partnership with leading pharmaceutical and biotechnology companies.

Location

150 Industrial Road
San Carlos
California
94070
United States of America

Contact

Phone: 650.631.3100
Fax: 650.631.3150
Email: NektarSC@nektar.com


News Articles [77 Associated News Articles listed on BioPortfolio]

Nektar Therapeutics Turns Negative After Reaching Record High

WASHINGTON (dpa-AFX) - After initially moving to the upside, shares of Nektar Therapeutics (NKTR) have turned lower over the course of the trading session on Monday. Nektar is currently down by 4....

Nektar and Syndax enter trial collaboration for metastatic melanoma

Nektar Therapeutics and Syndax Pharmaceuticals Inc. have paired up to evaluate the combination of Syndax’s entinostat with Nektar’s NKTR214 for metastatic melanoma patients whose disease progresse...

Nektar Therapeutics: Inhaling Success: An Interview with John Patton, CSO and Co-founder

Fintan Walton talks to John Patton, CSO and Co-founder of Nektar Therapeutics about the challenges he faced in setting up the firm and the company’s success to date. John describes how his research ...

IsoPlexis, Nektar Therapeutics in Immunotherapy Alliance

Will employ IsoCode Chip's single-cell functional profiling in collaboration with Nektar to profile effects of NKTR-214

Nektar Therapeutics: What The REVEAL Study Entails

Nektar recently secured a highly favorable deal with Bristol-Myers Squibb for the development of NKTR-214 with Opdivo and Opdivo plus Yervoy in 20 different cancer indications. Despite favorable terms...

Nektar and Takeda to test combination regimen for cancer

Nektar Therapeutics has entered into a clinical collaboration to investigate its NKTR-214 drug candidate in combination with Takeda Pharmaceutical’s TAK-659...Read More... The post Nektar and Takeda...

Nektar starts dosing in Phase Ib trial of NKTR-358 for SLE

Nektar Therapeutics has started dosing patients in a Phase Ib clinical trial designed to investigate NKTR-358 as a treatment for...Read More... The post Nektar starts dosing in Phase Ib trial of NKTR-...

Nektar Therapeutics doses first patient in REVEAL study

Nektar Therapeutics has dosed the first patient in the REVEAL study, a Phase I/II clinical trial designed to analyse the...Read More... The post Nektar Therapeutics doses first patient in REVEAL study...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

NEKTAR

We are a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapi...

Pearl Therapeutics, Inc.

Pearl Therapeutics is developing a pipeline of advanced respiratory products that will offer patients and their healthcare providers a choice of formulations and dosage strengths better suited to ...

Nektar Therapeutics

We are a biopharmaceutical company with a different approach to medicine. We develop drugs that are easier to take, safer to use, longer lasting and more effective. We look closely at existing therapi...

More Information about "NEKTAR" on BioPortfolio

We have published hundreds of NEKTAR news stories on BioPortfolio along with dozens of NEKTAR Clinical Trials and PubMed Articles about NEKTAR for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NEKTAR Companies in our database. You can also find out about relevant NEKTAR Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record